NovaBay Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
NovaBay Pharmaceuticals | D:发行公告
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Garlikov Julie
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Freiman Paul E.
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Sit Swan
NovaBay Pharmaceuticals | 4:持股变动声明-董事 WU MIJIA
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Zheng Yenyou
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Zheng Yongxiang
NovaBay Pharmaceuticals | D:发行公告
NovaBay Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
NovaBay Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Altium Capital Management, LP EIN:(4.99%),Altium Growth Fund, LP EIN:(4.99%)等
NovaBay Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Hudson Bay Capital Management LP(9.99%),Sander Gerber(9.99%)
NovaBay Pharmaceuticals | D:发行公告
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Freiman Paul E.
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Garlikov Julie
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Zheng Yenyou
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Zheng Yongxiang
NovaBay Pharmaceuticals | 4:持股变动声明-董事 Sit Swan
NovaBay Pharmaceuticals | 4:持股变动声明-董事 WU MIJIA
NovaBay Pharmaceuticals | D:发行公告
暂无数据
暂无数据